<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> is one major cause for <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> in healthy individuals with the prevalence being approximately 3.2-8.6% </plain></SENT>
<SENT sid="1" pm="."><plain>It is caused by a mutation in the promoter region of the UGT1A1-gene with a prolonged <z:chebi fb="2" ids="32497">TAA</z:chebi>-repeat coding for the enzyme <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronosyltransferase (A(TA)(7) <z:chebi fb="2" ids="32497">TAA</z:chebi> allele) </plain></SENT>
<SENT sid="2" pm="."><plain>After OLT, <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's disease</z:e> of the transplanted liver can cause <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, we looked for the presence of A(TA)(7) <z:chebi fb="2" ids="32497">TAA</z:chebi> alleles in pediatric liver transplant recipients with <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Laboratory results of 106 pediatric liver transplant recipients (aged 0-17 yr) were evaluated for elevated total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> over 2.0 mg/dL (conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> &lt;30%) </plain></SENT>
<SENT sid="5" pm="."><plain>In these patients, DNA of the liver graft was extracted from paraffin-embedded liver biopsy samples formerly taken for diagnostic reasons </plain></SENT>
<SENT sid="6" pm="."><plain>The DNA was analyzed for A(TA)(7) <z:chebi fb="2" ids="32497">TAA</z:chebi> alleles in the promoter region of the UGT1A1-gene </plain></SENT>
<SENT sid="7" pm="."><plain>In 4 of 106 pediatric liver transplant recipients we found <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> with total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> above 2.0 mg/dL (conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> &lt;30%) </plain></SENT>
<SENT sid="8" pm="."><plain>The analysis of the promoter region of the UGT1A1-gene of the liver grafts showed three homozygous A(TA)(7) <z:chebi fb="2" ids="32497">TAA</z:chebi> alleles (homozygous <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>) and one heterozygous A(TA)(7) <z:chebi fb="2" ids="32497">TAA</z:chebi> allele (heterozygous <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e>) </plain></SENT>
<SENT sid="9" pm="."><plain>This study shows that pediatric liver transplant recipients with <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> are very likely to have received a liver graft from a donor with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
</text></document>